About this journal
Aims and scope
Tissue Barriers is the first international interdisciplinary journal that focuses on the architecture, biological roles and regulation of tissue barriers and intercellular junctions. We publish high quality peer-reviewed articles that cover a wide range of topics including structure and functions of the diverse and complex tissue barriers that occur across tissue and cell types, including the molecular composition and dynamics of polarized cell junctions and cell-cell interactions during normal homeostasis, injury and disease state. Tissue barrier formation in regenerative medicine and restoration of tissue and organ function is also of interest.
Tissue Barriers publishes several categories of articles including: Original Research Papers, Short Communications, Technical Papers, Reviews, Perspectives and Commentaries, Hypothesis and Meeting Reports. Reviews and Perspectives/Commentaries will typically be invited. We also anticipate to publish special issues that are devoted to rapidly developing or controversial areas of research. Suggestions for topics are welcome.
Tissue Barriers objectives:
- Promote interdisciplinary awareness and collaboration between researchers working with epithelial, epidermal and endothelial barriers and to build a broad and cohesive worldwide community of scientists interesting in this exciting field.
- Comprehend the enormous complexity of tissue barriers and map cross-talks and interactions between their different cellular and non-cellular components.
- Highlight the roles of tissue barrier dysfunctions in human diseases.
- Promote understanding and strategies for restoration of tissue barrier formation and function in regenerative medicine.
- Accelerate a search for pharmacological enhancers of tissue barriers as potential therapeutic agents.
- Understand and optimize drug delivery across epithelial and endothelial barriers.
Publication Office:
Taylor & Francis Group
530 Walnut Street | Suite 850
Philadelphia, PA 19106
Journal metrics
Usage
- 100K annual downloads/views
Citation metrics
- 3.6 (2023) Impact Factor
- Q2 Impact Factor Best Quartile
- 4.4 (2023) 5 year IF
- 6.6 (2023) CiteScore (Scopus)
- Q1 CiteScore Best Quartile
- 0.810 (2023) SNIP
- 0.978 (2023) SJR
Speed/acceptance
- 24 days avg. from submission to first decision
- 43 days avg. from submission to first post-review decision
- 7 days avg. from acceptance to online publication
- 64% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
Editor-in-Chief
Kursad Turksen
University of Ottawa
Ottawa, Ontario, Canada
[email protected]
Editorial Board
David A. Antonetti - University of Michigan, Ann Arbor, MI, US
William A. Banks - University of Washington, Seattle, WA, US
Konstantin G. Birukov - University of Maryland School of Medicine, Baltimore, MD, US
Anthony Blikslager - NC State University, Raleigh, NC, US
Marjorie Brand - University of Ottawa, Ottawa, CA
Yan-Hua Chen - East Carolina University, Greenville, NC, US
Lina Dagnino - Wesetern University, London, ON, CA
Donna E. Davies - University of Southampton, Southampton, UK
Thomas P. Davis - University of Arizona College of Medicine, Tuscon, AZ
Maria A. Deli - Hungarian Academy of Sciences, Budapest, HU
Shanta Dhar - University of Miami Miller School of Medicine, FL, US
F. Jeffrey Dilworth - Ottawa Hospital Research Institute, Ottawa, CA
Jannette M. Dufour - Texas Tech University Health Sciences Center, Lubbock, TX, US
Michael B. Dwinell - Medical College of Wisconsin, Milwaukee, WI, US
Klaus Ebnet - University of Muenster, Muenster, DE
Britta Engelhardt - University of Bern, Bern, Switzerland
Michael Fromm - Charité - Universitätsmedizin Berlin, Berlin, DE
Susan Hagen - Harvard Medical School, Boston, MA
Jianghui Hou - Washington University Medical School, St. Louis, Missouri, USA
Walter Hunziker - Institute of Molecular and Cell Biology, Singapore, SG
Junichi Ikenouchi - Kyushu University, Fukuoka, JP
Andrei Ivanov - Cleveland Clinic Foundation, Cleveland, OH, US
Anna Jezierski - National Research Council, Ottawa, CA
Laura Kerosuo Pahlberg - National Institute of Dental and Craniofacial Research, Bethesda, MD, US
Takashi Kojima - Sapporo Medical University School of Medicine, Sapporo, JP
Masuo Kondoh - Showa Pharmaceutical University, Tokyo, JP
Antonis Kourtidis - Medical University of South Carolina, Charleston, SC, US
Michael Koval - Emory University School of Medicine, Atlanta, GA, US
Istvan A. Krizbai - Biological Research Center, Szeged, HU
Thomas Y. Ma - Pennsylvania State University, Hershey, PA, US
Tracy A. Martin - Cardiff, UK
Maja Matis - University of Münster, Münster, DE
Alexa L. Mattheyses - The University of Alabama at Birmingham, Birmingham, AL
Michael A. McGuckin - Mater Medical Research Institute, Brisbane, QLD, AU
Randall J. Mrsny - University of Bath, Bath, UK
Shigeo Ohno - Yokohama City University, Yokohama, JP
Mirna Perez-Moreno - University of Copenhagen, Copenhagen, DE
Pawin Pongkorpsakol - Princess Srisavangavadhana College of Medicine, Bangkok, TH
Fariba Rezaee - Cleveland Clinic, OH, US
Gerhard Rogler - University Hospital Zurich, Zurich, CH
Christos Samakovlis - Stockholm University, Stockhom, SE
Michael Sigal - Charité Universitätsmedizin, Berlin, DE
Peter G. Stanton - Hudson Institute of Medical Research, Clayton, VIC, AU
Sachiko Tsukita - Osaka University, Osaka, Japan
Jerrold R. Turner - Harvard Medical School, Boston, MA, US
Sven C.D. van IJzendoorn - University of Groningen, Groningen, NL
Alex J. Vecchio - University of Nebraska-Lincoln, Lincoln NE, US
Jian-Ying Wang - University of Maryland School of Medicine, Baltimore, MD, US
Neuhaus Winfried - Austrian Institute of Technology, Vienna, AT
Rebecca A. Wingert - University of Notre Dame, Notre Dame, IN
Abstracting and indexing
Tissue Barriers is abstracted/indexed in:
- National Library of Medicine
- PubMed Central (PMC)
- Medline
- Thomson Reuters
- Emerging Sources Citation Index
- Web of Science - Scopus
Open access
Tissue Barriers is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
Use our APC finder to calculate your article publishing charge
4 issues per year
Advertising information
Would you like to advertise in Tissue Barriers?
Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Tissue Barriers.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors